Iris Acquisition Corp II (IRAB) - Total Liabilities
Based on the latest financial reports, Iris Acquisition Corp II (IRAB) has total liabilities worth $7.43 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Iris Acquisition Corp II - Total Liabilities Trend (2025–2025)
This chart illustrates how Iris Acquisition Corp II's total liabilities have evolved over time, based on quarterly financial data. See IRAB current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Iris Acquisition Corp II Competitors by Total Liabilities
The table below lists competitors of Iris Acquisition Corp II ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Highly Group Co Ltd B
SHG:900910
|
China | $15.67 Billion |
|
Cartesian Therapeutics Inc.
NASDAQ:RNAC
|
USA | $436.51 Million |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
USA | $12.99 Million |
|
LIWANLI Innovation Co Ltd
TW:3054
|
Taiwan | NT$32.86 Million |
|
Bluerock Acquisition Corp. Class A Ordinary Shares
NASDAQ:BLRK
|
USA | $596.17K |
|
Garuda Construction & Engineering
NSE:GARUDA
|
India | Rs1.90 Billion |
|
Sanurhasta Mitra PT
JK:MINA
|
Indonesia | Rp13.06 Billion |
|
Galectin Therapeutics Inc
NASDAQ:GALT
|
USA | $146.00 Million |
Liability Composition Analysis (2025–2025)
This chart breaks down Iris Acquisition Corp II's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Iris Acquisition Corp II worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Iris Acquisition Corp II's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Iris Acquisition Corp II (2025–2025)
The table below shows the annual total liabilities of Iris Acquisition Corp II from 2025 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $182.62K | -- |
About Iris Acquisition Corp II
Iris Acquisition Corp II does not have significant operations. It focuses on entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. Iris Acquisition Corp II was incorporated in 2025 and is based in Dubai, the United Arab Emirates.